Hypothesis\n\nGermline mitochondria maintain low heteroplasmy not only through bottleneck selection but also via germline‑enriched mitochondrial‑derived peptides (MDPs) that directly modulate mitophagy and Balbiani body formation, thereby acting as a selective editing budget for somatic‑like quality control.\n\n## Rationale\n\n- The germline avoids age‑related mtDNA mutation accumulation seen in somatic tissue after 70 y (1).\n- SHLP2/3 reduce ROS and improve metabolism in vitro (2); humanin extends C. elegans lifespan via FOXO‑dependent autophagy (3).\n- No data exist on MDP expression in primordial germ cells (PGCs) or oocytes, nor on their role in the mitochondrial bottleneck.\n\n## Mechanistic Insight\n\nWe propose that a subset of MDPs—particularly SHLP2 and humanin—are transcriptionally up‑regulated in PGCs and early oocytes, where they:\n1. Bind yet‑uncharacterized receptors on the outer mitochondrial membrane to amplify PINK1‑Parkin mitophagy, preferentially eliminating organelles with high heteroplasmy.\n2. Interact with Balbiani body components (e.g., Bucky ball) to tether damaged mitochondria for sequestration and subsequent lysosomal degradation.\n3. Activate a germline‑specific FOXO‑autophagy axis that couples nutrient sensing to mtDNA quality control, effectively granting somatic cells a germline‑grade editing budget when ectopically expressed.\n\n## Testable Predictions\n\n1. Expression: RT‑qPCR and targeted proteomics will show SHLP2, SHLP3, and humanin mRNA/protein levels ≥2‑fold higher in human PGCs (weeks 4‑6 gestation) and mouse oocytes compared with matched somatic tissues.\n2. Functional knock‑out: Germ‑cell‑specific CRISPR‑Cas9 deletion of the MOTS‑c/SHLP2 loci will increase heteroplasmic mtDNA mutation load in F1 offspring by ≥30 % (measured by ultra‑deep sequencing) without affecting gross fertility.\n3. Rescue: Ectopic expression of SHLP2 in somatic mouse muscle (via AAV9-SHLP2) will recapitulate germline‑like mitophagy flux (measured by mt-Keima) and reduce age‑associated heteroplasmy accumulation after 18 months.\n4. Mechanistic link: Co‑immunoprecipitation in oocytes will reveal SHLP2 binding to a putative receptor (e.g., CNTFR-like) and to PINK1, with loss‑of‑function abrogating PINK1 phosphorylation after CCCP treatment.\n\n## Experimental Approach\n\n- Sample collection: Human fetal gonadal tissue (ethically approved) and mouse ovaries at E12.5, E14.5, and adult.\n- Assays: RT‑qPCR, parallel reaction monitoring (PRM) proteomics, immunoblotting for PINK1/Parkin, mt-Keima flow cytometry, duplex sequencing of mtDNA.\n- Genetics: ZsGreen‑Cre‑driven floxed SHLP2 allele; AAV9-SHLP2 somatic rescue.\n- Readouts: Heteroplasmy shift, follicle count, oocyte quality (IVF success), germline transmission.\n\n## Falsifiability\n\nIf germline MDP expression is not elevated, or if germ‑cell‑specific MDP loss does not increase offspring heteroplasmy, the hypothesis that MDPs contribute to the germline’s “cheating” mechanism is refuted. Conversely, somatic rescue reducing heteroplasmy would support the idea of transferring a germline‑grade editing budget.\n\n## Implications\n\nConfirming this link would reposition MDPs from generic stress signals to gatekeepers of transgenerational genome integrity, opening therapeutic avenues for preventing mtDNA disease inheritance.
